<--- Back to Details
First PageDocument Content
Clinical pharmacology / Food and Drug Administration / Therapeutics / United States Public Health Service / Zalcitabine / Didanosine / Pharmaceutical sciences / Medicine / Pharmacology
Date: 2013-05-28 10:53:48
Clinical pharmacology
Food and Drug Administration
Therapeutics
United States Public Health Service
Zalcitabine
Didanosine
Pharmaceutical sciences
Medicine
Pharmacology

Microsoft Word[removed]Drug and Device Committee Final Report

Add to Reading List

Source URL: www.afdo.org

Download Document from Source Website

File Size: 145,92 KB

Share Document on Facebook

Similar Documents